IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure. This includes bringing AI, Machine Learning and smart image analysis methods to ensure the speed and cost-effectiveness, while delivering true insights about your mechanism of action and patients’ response, in real-time.
Our proprietary cloud platform DYNAMIKA is at the core of any clinical trial that we deliver for our bio-pharma partners. Through secure cloud infrastructure, DYNAMIKA supports robust image upload and collection in multi-site trials. This gives real-time visibility of the trial progress and full control over the image quality. Once on the cloud, the images are reviewed by our radiology team or AI-driven methods, selected for each study and integrated into DYNAMIKA. Certified: ISO13485, FDA510K, CE, 21 CFR Part 11
We strategically use imaging, such as MRI, CT, and PET to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a successful H2H or superiority trial, our science, operations and technology teams will work with you to develop the right solution.
Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.
Do you want to join a fast-paced company using computer science, medical imaging and bold thinking to bring the best treatments to patients? We are hiring in Europe and USA giving you an international career, supportive team and ability to make real impact!
Chief Excecutive Officer of IAG and mathematician with 10+ years expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.
Chair of IAG’s Scientifc Advisory Board and ex-head of R&D for Lilly, with 20+ years of R&D global pharmaceutical companies, developing treatments in immunology, neurology and oncology.
IAG’s CTO and expert in medical image analysis, data mining, algorithm development, medical image and video processing, mathematical, stochastic and forecasting modelling and numerical analysis.
Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.
IAG’s COO and Industry’s Veteran with 20+ years of experience growing teams and scaling operations to delivery programs for Bio-Pharma industry.
IAG’s CFO and Investment Professional with 20+ years of Expertise in Life science Industry
IAG’s Head in Oncology and Neuro-Oncology Clinical Research and Expert in using cutting-edge imaging approaches in clinical research of brain tumours and neurological conditions.
Board-certified oncologist and internally renowned cancer researcher
IAG’s Chief Scientific Alliance Officer and Bio-Partnering Director with 10+ years of scientific expertise in medical imaging and advising life science companies.
IAG’s Expert in molecular imaging, radiomics and clinical research with a special focus on implementing advanced imaging in clinical trials.
Research Professor with expertise and focus on developing new treatments for osteoarthritis.
Dr. Valenzuela is a recognized leader in the treatment of complex cases of Arthritic and Rheumatic diseases.
With special interest in MRI and US of joints affected by rheumatoid arthritis, Prof. Mikkel Østergaard co-authored more than 125 scientific articles.
Dr. Tzaribachev is running one of the largest clinics and is a hands-on paediatric rheumatologist at the University Children’s Hospital in Tuebingen, Germany.
Dr. Carrino is an internationally renowned radiologist with particular expertise in diagnostic imaging and percutaneous image-guided intervention.
Musculoskeletal radiologist expert in bone and soft tissue sarcoma imaging. Co-author of 75 peer reviewed publications.
Jeremy has served as a Global Client Adviser for Healthcare in Oracle for 10 years.
Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.
Extensive knowledge in advanced oncology imaging and over 15 years of hands-on experience in CT, MR and US clinical research.
Dr. Mian is a board certified radiologist with a certificate of added qualification in Neuroradiology.
International PI and Head of Scleroderma Programme at the UK’s largest Rheumatic and Musculoskeletal Hospital.
Diagnostic radiologist in Boston Medical Center, specializing in thoraco-abdominal imaging.
Physician with over 18 years pharmaceutical experience in Medical and Regulatory affairs.
Scientific expert in preclinical development and translational medicine.
Scientific expert with 25 years of commercial pharmaceutical leadership focused on arthritis and inflammation.
Expert in transforming the process of medical innovation in response to the future challenges facing healthcare worldwide, and advising and assisting life science enterprises.
Advisor and Expert in Assessment of Degenerative Changes in Osteoarthritis
Expert in clinical research with a special focus on implementing risk-based monitoring and cost-benefit optimization.
20+ years’ experience in clinical trial design and international leadership in studies of biologic and small molecular therapies in RA and AS.
Leading researcher in emerging therapies and disease state metrics for rheumatic diseases.
Expert with strong interests relating to the understanding of platinum resistance in ovarian cancer.
Expert in Musculoskeletal Clinical Research & Biomarkers
Recognized leader in the surgical resection and experimental treatment of complex brain tumors
IAG’s Head of Musculoskeletal Imaging Research and distinguished scientist with 18+ years expertise in radiology, imaging and use of AI in inflammatory, rheumatic and degenerative joint diseases.
IAG’s Cell and Gene Therapy Expert and Senior Leader, Board Member and Investment Committee Member.
IAG’s Radiology Expert and Opinion Leader in Brain Tumor Imaging and clinical research with a special focus on implementing advanced imaging in Glioma/Glioblastoma.
IAG’s Radiology Expert and Opinion Leader in Imaging of Lung Diseases, including cancer, infection and pneumonia.
IAG’s Ophtalmology Expert and Clinical Trials Fellow, with extensive experience in the management and study of AMD, retinopathies, uveitis and other conditions of the eye.
IAG’s Oncology Expert with extensive experience in image analysis and image review using RECIST 1.1., iRECIST and other oncology reading criteria.
